Department of Oncology

Chair

Ching-Hon Pui, MD

Co-Chair

Amar Gajjar, MD

Departmental Focus

The overall mission of the Oncology Department is to improve cure rates for children with cancer while reducing the side effects of therapy through a coordinated program of clinical and laboratory-based research, patient care and education. Recent gains have been seen in the treatment outcome for two of the most frequent forms of childhood cancer (a 94 percent survival rate for acute lymphoblastic leukemia and 71 percent for acute myeloid leukemia).

Oncology faculty share their unique clinical expertise with colleagues worldwide through the hospital’s International Outreach Program. They are also involved in all programs of the Cancer Center through research aiming at identifying novel drugs and treatment modalities, defining the clinical significance of recently discovered genetic abnormalities of cancer cells, and understanding mechanisms of cancer and drug resistance. The ultimate goals of this research are to provide curative therapy to every child with cancer and help develop preventive measures.

Contact Us

Department of Oncology
MS 260, Room C6056
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678

ching-hon.pui@stjude.org
Telephone: (901) 595-4329
FAX: (901) 521-1751

Preferred contact method: email

Faculty

Gregory T. Armstrong, MD  Pediatric neuro-oncology and cancer survivorship

Richard A. Ashmun, PhD  Applications of flow cytometry & cell separation

Justin N. Baker, MD  Pediatric palliative and end-of-life care

Deepa Bhojwani, MD  Improving therapy for childhood leukemia/lymphoma

Rachel C. Brennan, MD  Retinoblastoma, novel therapeutics, renal tumors

Alberto Broniscer, MD  Biology and treatment of high-grade gliomas

Sara M. Federico, MD  Drug development, pediatric soft tissue sarcomas

Kevin W. Freeman, PhD  Genetic interactions that give rise to neuroblastoma

Wayne L. Furman, MD  New drug development, neuroblastoma, liver tumors

Amar Gajjar, MD  Novel treatments for children with brain tumors

Richard J. Gilbertson, MD, PhD  The cellular and molecular origins of brain tumors

Daniel M. Green, MD  Adverse cardiac & reproductive effects of therapy

Tanja A. Gruber, MD, PhD  Pathogenesis of infantile leukemia

Mark E. Hatley, MD, PhD  Cellular and molecular origins of rhabdomyosarcoma

Scott C. Howard, MD, MS  Leukemia and lymphoma, international outreach

Melissa M. Hudson, MD  Health outcomes after childhood cancer

Hiroto Inaba, MD, PhD  New therapeutic strategies for leukemia

Sima Jeha, MD  Childhood leukemias, developmental therapeutics

Sue C. Kaste, DO   Skeletal toxicities in childhood cancer survivors

Catherine G. Lam, MD, MPH  International outreach, solid tumors, improving adolescent outcomes

Joseph H. Laver, MD  Stem cell transplantation & non-Hodgkin lymphoma

Deena R. Levine, MD  Pediatric palliative and end of life care

Monika Metzger, MD   Hodgkin & non-Hodgkin lymphomas, leukemias, international outreach

Daniel A. Mulrooney, MD, MS  Cardiovascular outcomes of cancer therapy

Fariba Navid, MD   Treatment of pediatric sarcomas and melanoma

Alberto Pappo, MD  New therapies for sarcomas and rare pediatric cancers

Ching-Hon Pui, MD  Biology and treatment of childhood leukemia

Ibrahim Qaddoumi, MD, MS  Low-grade gliomas, retinoblastoma, telemedicine

Raul C. Ribeiro, MD  International outreach, hematological malignancies

Giles W. Robinson, MD  Origin and genomics of medulloblastoma, translational studies

Jeffrey E. Rubnitz, MD, PhD  Treatment of acute myeloid leukemia

John T. Sandlund, MD  Clinical and biologic investigation of NHL and ALL

Victor M. Santana, MD  Novel therapeutics, neuroblastoma, research ethics

Sheri L. Spunt, MD  Soft tissue sarcomas of childhood

Cynthia Wetmore, MD, PhD  Developmental therapeutics, Phase I/II studies in neuro-oncology

Judith A. Wilimas, MD  International outreach, Wilms tumor, sickle cell disease

Karen D. Wright, MD  Ependymoma, atypical teratoid rhabdoid tumors, infant brain tumors